The Enterprise Value as of March 2026 (TTM) for Compass Therapeutics, Inc. (CMPX) is 696.89M

According to Compass Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 696.89M. This represents a change of 39.80% compared to the average of 498.50M of the last 4 quarters.

Compass Therapeutics, Inc. (CMPX) Historical Enterprise Value (quarterly & annually)

How has CMPX Enterprise Value performed in the past?

The mean historical Enterprise Value of Compass Therapeutics, Inc. over the last ten years is 323.99M. The current 696.89M Enterprise Value has changed 21.41% with respect to the historical average. Over the past ten years (40 quarters), CMPX's Enterprise Value was at its highest in in the December 2025 quarter at 971.80M. The Enterprise Value was at its lowest in in the December 2018 quarter at -4679.00.

Compass Therapeutics, Inc. (CMPX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Compass Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Compass Therapeutics, Inc. (CMPX) Average Enterprise Value

How has CMPX Enterprise Value performed in the past?

The current Enterprise Value of Compass Therapeutics, Inc. (CMPX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Compass Therapeutics, Inc. (CMPX) Enterprise Value vs. Peers

How is CMPX’s Enterprise Value compared to its peers?

Compass Therapeutics, Inc.’s Enterprise Value is greater than Fulcrum Therapeutics, Inc. (222.86M), greater than 4D Molecular Therapeutics, Inc. (398.60M), less than Ocugen, Inc. (827.76M), greater than Bicycle Therapeutics plc (-311382932.00), greater than Gossamer Bio, Inc. (295.11M), less than Lexicon Pharmaceuticals, Inc. (743.93M), greater than Monopar Therapeutics Inc. (275.79M), less than Corvus Pharmaceuticals, Inc. (1.28B), less than KalVista Pharmaceuticals, Inc. (762.34M), less than Omeros Corporation (982.59M),

Build a custom stock screener for Compass Therapeutics, Inc. (CMPX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Compass Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Compass Therapeutics, Inc. (CMPX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Compass Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.